RECOMBINANT THERAPEUTIC ANTIBODIES AND PROTEINS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024 - 2031)

Table of Contents (Version-2026)

1. Research Objective and Assumption

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
• Market Definition and Scope
• Executive Summary
• Market Snippet, By Drug Class
• Market Snippet, By Application
• Market Snippet, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
• Drivers
• Restraints
• Market Opportunities
• Market Trends
• Pipeline Analysis
• Drug Development Challenges
• New Market Entrants
• Regulatory Scenario
• PEST Analysis
• Porter’s Analysis

4. Global Recombinant Therapeutic Antibodies and Proteins Market, By Drug Class, 2016 – 2026, (US$ Million)

• Introduction
• Market Share Analysis, 2018 and 2026 (%)
• Y-o-Y Growth Analysis, 2017–2026
• Segment Trends
• Plasma Protein
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
• Growth Factors
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
• Fusion Proteins
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
• Monoclonal Antibodies
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
• Hormones
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
• Enzyme
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
• Coagulation Factors
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
• Others
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)

5. Global Recombinant Therapeutic Antibodies and Proteins Market, Application, 2016 – 2026, (US$ Million)

• Introduction
• Market Share Analysis, 2018 and 2026 (%)
• Y-o-Y Growth Analysis, 2017–2026
• Segment Trends
• Oncology
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
• Hematology
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
• Immunology
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
• Endocrinology
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
• Infectious Disease
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
• Cardiovascular Disease
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
• Others
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
6. Global Recombinant Therapeutic Antibodies and Proteins Market, By Region, 2016 – 2026, (US$ Million)
• Introduction
• Market Share Analysis, By Region, 2018 and 2026 (%)
• Y-o-Y Growth Analysis, For Regions, 2017–2026
• Regional Trends
• North America
• Market Size and Forecast, By Drug Class, 2016 – 2026, (US$ Million)
• Market Size and Forecast, By Application, 2016 – 2026, (US$ Million)
• Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
• U.S.
• Canada
• Latin America
• Market Size and Forecast, By Drug Class, 2016 – 2026, (US$ Million)
• Market Size and Forecast, By Application, 2016 – 2026, (US$ Million)
• Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Europe
• Market Size and Forecast, By Drug Class, 2016 – 2026, (US$ Million)
• Market Size and Forecast, By Application, 2016 – 2026, (US$ Million)
• Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
• Germany
• U.K.
• France        
• Italy
• Spain
• Russia
• Rest of Europe
• Asia Pacific
• Market Size and Forecast, By Drug Class, 2016 – 2026, (US$ Million)
• Market Size and Forecast, By Application, 2016 – 2026, (US$ Million)
• Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
• China
• India
• Japan
• Australia
• South Korea
• ASEAN
• Rest of Asia Pacific
• Middle East
• Market Size and Forecast, By Drug Class, 2016 – 2026, (US$ Million)
• Market Size and Forecast, By Application, 2016 – 2026, (US$ Million)
• Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
• GCC
• Israel
• Rest of Middle East
• Africa
• Market Size and Forecast, By Drug Class, 2016 – 2026, (US$ Million)
• Market Size and Forecast, By Application, 2016 – 2026, (US$ Million)
• Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
• South Africa
• Central Africa
• North Africa

7. Competitive Landscape

• Heat Map Analysis
• Company Profiles
• Abbott*
• Company Overview
• Product Portfolio
• Key Highlights
• Financial Overview
• Market Strategy
• Amgen Inc.
• Company Overview
• Product Portfolio
• Key Highlights
• Financial Overview
• Market Strategy
• Biogen Inc.
• Company Overview
• Product Portfolio
• Key Highlights
• Financial Overview
• Market Strategy
• Eli Lilly and Company
• Company Overview
• Product Portfolio
• Key Highlights
• Financial Overview
• Market Strategy
• F. Hoffmann-La Roche
• Company Overview
• Product Portfolio
• Key Highlights
• Financial Overview
• Market Strategy
• Johnson and Johnson
• Company Overview
• Product Portfolio
• Key Highlights
• Financial Overview
• Market Strategy
• Merck & Co.
• Company Overview
• Product Portfolio
• Key Highlights
• Financial Overview
• Market Strategy
• Novo Nordisk
• Company Overview
• Product Portfolio
• Key Highlights
• Financial Overview
• Market Strategy
• Pfizer Inc.
• Company Overview
• Product Portfolio
• Key Highlights
• Financial Overview
• Market Strategy
• Sanofi S.A.
• Company Overview
• Product Portfolio
• Key Highlights
• Financial Overview
• Market Strategy
• Analyst Views

8. Section

• References
• Research Methodology
• About us and Sales Contact

*Browse 22 market data tables and 27 figures on "Recombinant Therapeutic Antibodies and Proteins Market - Global forecast to 2026”

.